^
BIOMARKER:

ALK wild-type

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
ALK wild-type
Non Small Cell Lung Cancer
atezolizumab
Sensitive
:
C3
Nat Med - 2 weeks - (New C3)
ALK wild-type
Lung Non-Squamous Non-Small Cell Cancer
atezolizumab
Sensitive
:
B
Cancer Med - 3 weeks - (New B)
ALK wild-type
Non Small Cell Lung Cancer
durvalumab
Sensitive
:
B
ALK wild-type
Lung Non-Squamous Non-Small Cell Cancer
cemiplimab
Sensitive
:
B
ALK wild-type
Lung Non-Small Cell Squamous Cancer
cemiplimab
Sensitive
:
B
ALK wild-type
Non Small Cell Lung Cancer
toripalimab
Sensitive
:
C2
ALK wild-type
Lung Non-Squamous Non-Small Cell Cancer
tislelizumab
Sensitive
:
C3
ALK wild-type
Non Small Cell Lung Cancer
AK112
Sensitive
:
C3
ALK wild-type
Lung Cancer
crizotinib
Sensitive
:
D